Leqing Cao

机构：Peking University, Peking University People's Hospital

发表论文 28 篇 · 总被引 114 次 · h-index 7

代表论文

• Prevalence and risk factors of antibodies to human leukocyte antigens in haploidentical stem cell transplantation candidates: A multi-center study (2018 · Human Immunology · 被引 17)
• Vedolizumab provides a new hope of acute graft-versus-host disease prophylaxis through immune regulation (2024 · The Innovation Medicine · 被引 10)
• Th2 polarization in target organs is involved in the alleviation of pathological damage mediated by transplanting granulocyte colony-stimulating factor-primed donor T cells (2020 · Science China Life Sciences · 被引 10)
• Relationship of Cell Compositions in Allografts with Outcomes after Haploidentical Transplantation for Acquired Severe Aplastic Anemia (2018 · Chinese Medical Journal · 被引 10)
• Quizartinib is a good option for AML patients with FLT3-ITD mutations (2023 · The Innovation Medicine · 被引 9)
• Peripheral blood stem cell transplantation from haploidentical related donor could achieve satisfactory clinical outcomes for intermediate- or high-risk adult acute myeloid leukemia patients (2023 · Bone Marrow Transplantation · 被引 8)